Cingulate Inc.

CINGNASDAQHealthcare● Active

$4.53

+$0.04(+0.78%)

Market Cap$25395352

P/E Ratio—

52W High$11.89

52W Low$3.16

Avg Volume675K

Open$4.50

Beta-0.85

Overview

Cingulate Inc. (CING) Free Cash Flow & Analysis

Annual & trailing free cash flow, FCF margin, YoY change, valuation ratios, and peer context.

CING · free cash flow · updated Jun 9, 2026

Core FCF metrics

CING · FCF · TTM · margin & CAGR

Free cash flow was −$17.4M for FY2025 (fiscal year ending 2025-12-31), up 6.7% year-over-year

FY2025 Free Cash Flow−$17.4M▲ +6.7% YoY

Trailing 12M (TTM)−$19.8Mtrailing 4 quarters sum

FCF Margin——

3-Year CAGRN/AN/A — contains negative FCF

5-Year CAGRN/AN/A — contains negative FCF

FormulaFCF = Operating Cash Flow − Capital ExpendituresTTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0

Source: FMP /cash-flow-statement · SEC 10-K / 10-Q · USDUpdated: Jun 9, 2026

Annual free cash flow history

FCF ($B, upper) · YoY Growth % (lower)

Positive FCFNegative FCF

Free Cash Flow

YoY Growth %

Annual free cash flow data

CING · free cash flow history · annual / quarterly

Fiscal YearOperating CFCapExFree Cash FlowYoY ChangeFCF Margin

FY2025Latest−$17.2M(0M)−$17.4M▲ +6.7%—

FY2024−$18.5M(0M)−$18.7M▼ 22.3%—

FY2023−$15.0M(0M)−$15.3M▲ +4.8%—

FY2022−$15.9M(0M)−$16.0M▼ 42.6%—

FY2021−$10.4M(1M)−$11.2M▼ 55.9%—

FCF = Operating Cash Flow − Capital Expenditures · CapEx shown as (negative) · Source: SEC filings via FMP

FCF valuation metrics

CING · P/FCF · FCF yield · FCF per share

Cingulate Inc. (CING) reported negative free cash flow of −$0.02B. FCF-based valuation ratios are not meaningful when FCF is negative.

FCF Yield (TTM)

N/A

Free Cash Flow ÷ Market Cap

per FMP freeCashFlowYieldTTM definition

FCF per Share (TTM)

N/A

TTM FCF ÷ Shares Outstanding

Price / FCF

N/A

Share Price ÷ FCF per Share

EV / FCF (TTM)

N/A

Enterprise Value basis

FCF-based valuation ratios are only meaningful when free cash flow is positive. Negative FCF indicates capital expenditures exceeded operating cash flow.

Source: FMP /key-metrics-ttm · /cash-flow-statement Q · /income-statementFY2025 · 2025-12-31

Cash flow statement summary

CING · cash flow statement · operating / investing / financing

For FY2025, Cingulate Inc. generated −$17.2M in operating cash flow and spent 0M in capital expenditures, yielding −$17.4M in free cash flow.

Operating Activities

−$17.2M

Cash from core business operations

2025-12-31

Investing Activities

−$0.2M

CapEx, acquisitions & investments

2025-12-31

Financing Activities

+$16.1M

Buybacks, dividends & debt

2025-12-31

FCF FormulaOperating CF (−$17.2M) − |CapEx| (0M) = FCF (−$17.4M)

For the complete Operating / Investing / Financing line-item breakdown:

View Full Cash Flow Statement →

Free cash flow vs peers (Healthcare)

CING vs peers · FCF

#CompanyFree Cash FlowYoYFCF MarginRelative

Cingulate Inc.YOU

CING

−$17.4M+6.7%—

Loss

UnitedHealth Group Incorporated

UNH

$16.07B-22.4%3.6%

82%

Eli Lilly and Company

LLY

$8.97B+2065.6%13.8%

46%

Healthcare · Sorted by FCF · FMP /cash-flow-statementFull FCF Rankings →

About Free Cash Flow & Methodology

Cingulate Inc. (CING) reported free cash flow of −$17.4M for FY2025 (fiscal year ending 2025-12-31), up 6.7% year-over-year.

Cingulate Inc. has reported negative free cash flow in recent periods, indicating capital expenditures have exceeded operating cash flow. Data available for 7 fiscal years.

Data sourced from FMP /cash-flow-statement · SEC 10-K / 10-Q · USD.

Q&A and summaries align with SEC 10-K/10-Q cash flow disclosures and FMP /cash-flow-statement where noted.

Revenue Financial statements Net income Earnings Forecast Price history Market cap Cash on hand P/E ratio

Frequently asked questions

CING free cash flow · 8 questions

Cingulate Inc. free cash flow was −$17.4M for FY2025, up 6.7% year-over-year. On a trailing twelve-month (TTM) basis, free cash flow stands at −$19.8M.

CING free cash flowCING FCFCING FCF 2025CING free cash flow TTM

▸ Source: FMP /cash-flow-statement · US GAAP · Cingulate Inc. · Cingulate Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 9, 2026